The activation of CD40 with a CD40 agonist in combination with gemcitabine is indicated to promote accumulation of tumoricidal macrophages within the tumors in the KPC mouse model, which resulted in stromal collapse and tumor regression in the KPC mouse model and some advanced-stage pancreatic cancer patients [103,104]. This evidence concerns the gene CD40 and pancreatic neoplasm.